Overview

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Collaborator:
Astellas Pharma Inc
Treatments:
Diphosphonates